 |
|
SMi Pharmaceutical conferences are attended by high level executives, on average two thirds of delegates are of Director level or higher from within the pharmaceutical, biotechnology and associated industries.
Forthcoming SMi events include the following:
|
 |
 |
Conference: Drug Delivery Global Summit
22nd to 23rd September 2008, London
|
|
|
Executive Briefing: Metabolic Diseases: The Opportunity, Drug Discovery Approaches and Case Studies
23rd September 2008, London
|
|
|
Executive Briefing: Nanotechnology and Drug-Device Integration
24th September 2008, London
|
|
|
Conference: Metabolic Diseases
24th to 25th September 2008, London
|
|
|
Conference: Key Opinion Leaders
29th to 30th September 2008, London
|
|
|
Executive Briefing: Good relationship practice (GRP): Nature or nurture?
1st October 2008, London
|
|
|
Conference: Conducting Clinical Trials in Europe
6th to 7th October 2008, Frankfurt
|
|
|
Executive Briefing: Conducting Paediatric Clinical Trials in the European Union
8th October 2008, Frankfurt
|
|
|
Executive Briefing: Health Claim Regulation – Challenge and chance for the industry
21st October 2008, London
|
|
|
Conference: Nutraceuticals and Functional Foods
22nd to 23rd October 2008, London
|
|
|
Conference: Point of Care Diagnostics
27th to 28th October 2008, London
|
|
|
Conference: European Pharmaceutical Pricing & Reimbursement
28th to 29th October 2008, Munich
|
|
|
Executive Briefing: Diagnostic Point of Care Testing (POCT) in the Total Healthcare Arena
29th October 2008, London
|
|
|
Executive Briefing: The changing P&R landscape in Europe and implications for the pharmaceutical industry
30th October 2008, Munich
|
|
|
Conference: IT Qualification in the Pharmaceutical Industry
17th to 18th November 2008, London
|
|
|
Executive Briefing: Novel Rapid Cell Methods in Diagnostics and Toxicology / Pharma Applications
18th November 2008, London
|
|
|
Executive Briefing: Cross Systems Validation for Interfaces
19th November 2008, London
|
|
|
Conference: Cell-Based Assays
19th to 20th November 2008, London
|
|
|
Conference: Clinical Trials in CNS
25th to 26th November 2008, London
|
|
|
Executive Briefing: Will Boosting with a High Selective 5HT2A/D4 Antagonist give Next Decade’ CNS Drugs?
27th November 2008, London
|
|
|
Masterclass: Facilitating RNAi Screening and miRNA Research
2nd December 2008, Central London
|
|
|
Masterclass: Intellectual Property and Generics Masterclass
3rd December 2008, Central London
|
|
|
Conference: Cold Chain Distribution
3rd to 4th December 2008, London
|
|
|
Masterclass: Instrumentation used in PAT/QbD: Theory, Applications, and Validation Issues for Pharmaceutical Products
4th December 2008, Central London
|
|
|
Masterclass: Therapeutic vaccines against IgE mediated allergies
10th December 2008, Central London
|
|
|
Conference: Paediatric Clinical Trials
19th to 20th January 2009, London
|
|
|
Conference: Pre-Filled Syringes
21st to 22nd January 2009, London
|
|
|
Executive Briefing: Lessons learned in ELN implementations across different industries
27th January 2009, London
|
|
|
Executive Briefing: Electronic Lab Notebooks for Life Sciences R&D
27th January 2009,
|
|
|
Conference: Electronic Laboratory Notebooks
28th to 29th January 2009, London
|
|
|
Conference: Biomarkers Summit
2nd to 3rd February 2009, London
|
|
|
Executive Briefing: Bayesian Adaptive Dose Finding Studies
3rd February 2009,
|
|
|
Conference: Adaptive Designs in Clinical Drug Development
4th to 5th February 2009, London
|
|
|
Conference: Pharmaceutical Parallel Trade
11th to 12th February 2009, London
|
|
|
Conference: Stem Cells: Drug Discovery and Therapeutics
16th to 17th February 2009,
|
|
|
Conference: Advances and Progress in Drug Design VIII
23rd to 24th February 2009, London
|
|
|
Executive Briefing: Maximising the impact of protein structural information in drug discovery research
25th February 2009,
|
|
|
Conference: Controlled Release
11th to 12th March 2009, London
|
|
Site Map
